Sartorius (OTCMKTS:SARTF) Short Interest Update

Sartorius (OTCMKTS:SARTF) saw a significant increase in short interest in April. As of April 30th, there was short interest totaling 2,331 shares, an increase of 407.8% from the April 15th total of 459 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is presently ? days. Currently, 0.0% of the company’s stock are sold short.

Sartorius Price Performance

SARTF stock remained flat at $212.35 during trading on Thursday. Sartorius has a 52-week low of $181.58 and a 52-week high of $226.33. The firm has a 50 day moving average of $224.09 and a 200 day moving average of $220.75. The company has a market capitalization of $7.27 billion, a PE ratio of 98.77 and a beta of 0.98. The company has a debt-to-equity ratio of 0.89, a current ratio of 0.95 and a quick ratio of 0.49.

About Sartorius

Sartorius AG, trading in the U.S. over the counter under the symbol SARTF, is a Germany-based provider of laboratory and bioprocessing equipment for the pharmaceutical, biotechnology and research industries. The company is organized into two core divisions: Bioprocess Solutions, which focuses on single-use consumables, filtration technologies and upstream and downstream processing systems; and Lab Products & Services, which supplies laboratory instruments, consumables and services, including balances, pipettes, cell counting systems and water purification units.

The Bioprocess Solutions segment serves customers engaged in the development and manufacture of biopharmaceuticals, vaccines and advanced therapies.